Comparative risk of major bleeding with new oral anticoagulants (NOACs) and phenprocoumon in patients with atrial fibrillation: a post-marketing surveillance study - Hohnloser, SH; Basic, E; Nabauer, M (Clin Res Cardiol, 2017)